Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status. [electronic resource]
Producer: 20111220Description: 1533-41 p. digitalISSN:- 1532-1827
- Animals
- Antimetabolites, Antineoplastic -- pharmacology
- Azacitidine -- pharmacology
- Base Sequence
- DNA Primers
- Enzyme-Linked Immunosorbent Assay
- Histocompatibility Antigens Class I -- immunology
- Human papillomavirus 16 -- isolation & purification
- Immunotherapy
- Male
- Methylation
- Mice
- Mice, Inbred C57BL
- Neoplasms, Experimental -- drug therapy
- Real-Time Polymerase Chain Reaction
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.